| Wesley Allen Clark, MD | |
|
920 Avenue B, Marrero, LA 70072-3112 | |
| (504) 349-6804 | |
| (504) 349-6844 |
| Full Name | Wesley Allen Clark |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 920 Avenue B, Marrero, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225220551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 202923 (Louisiana) | Secondary |
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 202923 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Omni Home Care | Mandeville, LA | Home health agency |
| West Jefferson Medical Center | Marrero, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| L Thomas Cashio Md And Mark Juneau Jr Md,pc | 2668562448 | 6 |
News Archive
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus (HSV) type 2 antigens. The addition of these patents complements the novel antigens discovered by Genocea's unique and proprietary antigen discovery technology. The combination of Genocea's novel intellectual property with the patent estate from the University of Washington provides the Company with a broad compendium of HSV antigen patents.
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
The epigenetic modifications, which alter the way genes function without changing the underlying DNA sequence, can apparently be detected in the blood of pregnant women during any trimester, potentially providing a simple way to foretell depression in the weeks after giving birth, and an opportunity to intervene before symptoms become debilitating.
Invetech, a leader in instrument development, custom automation, and contract manufacturing, and Vaxxas, a biotechnology start-up and developer of the Nanopatch™ needle-free drug delivery technology, have been named winners of the 2015 Good Design Award for development of the Nanopatch Jet Coating Instrument, an advanced technology platform to support needle-free dermal drug delivery research and product development. The award was announced last evening at the Good Design Awards Gala Night held in Sydney, Australia.
A study by researchers at the UCLA Stroke Center found that stroke and cardiovascular disease have exacted an enormous toll on Hollywood stars.
› Verified 7 days ago
| Entity Name | L Thomas Cashio Md & Mark Juneau Jr Md,pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336288752 PECOS PAC ID: 2668562448 Enrollment ID: O20071217000602 |
News Archive
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus (HSV) type 2 antigens. The addition of these patents complements the novel antigens discovered by Genocea's unique and proprietary antigen discovery technology. The combination of Genocea's novel intellectual property with the patent estate from the University of Washington provides the Company with a broad compendium of HSV antigen patents.
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
The epigenetic modifications, which alter the way genes function without changing the underlying DNA sequence, can apparently be detected in the blood of pregnant women during any trimester, potentially providing a simple way to foretell depression in the weeks after giving birth, and an opportunity to intervene before symptoms become debilitating.
Invetech, a leader in instrument development, custom automation, and contract manufacturing, and Vaxxas, a biotechnology start-up and developer of the Nanopatch™ needle-free drug delivery technology, have been named winners of the 2015 Good Design Award for development of the Nanopatch Jet Coating Instrument, an advanced technology platform to support needle-free dermal drug delivery research and product development. The award was announced last evening at the Good Design Awards Gala Night held in Sydney, Australia.
A study by researchers at the UCLA Stroke Center found that stroke and cardiovascular disease have exacted an enormous toll on Hollywood stars.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wesley Allen Clark, MD 920 Avenue B, Marrero, LA 70072-3112 Ph: (504) 349-6804 | Wesley Allen Clark, MD 920 Avenue B, Marrero, LA 70072-3112 Ph: (504) 349-6804 |
News Archive
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus (HSV) type 2 antigens. The addition of these patents complements the novel antigens discovered by Genocea's unique and proprietary antigen discovery technology. The combination of Genocea's novel intellectual property with the patent estate from the University of Washington provides the Company with a broad compendium of HSV antigen patents.
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
The epigenetic modifications, which alter the way genes function without changing the underlying DNA sequence, can apparently be detected in the blood of pregnant women during any trimester, potentially providing a simple way to foretell depression in the weeks after giving birth, and an opportunity to intervene before symptoms become debilitating.
Invetech, a leader in instrument development, custom automation, and contract manufacturing, and Vaxxas, a biotechnology start-up and developer of the Nanopatch™ needle-free drug delivery technology, have been named winners of the 2015 Good Design Award for development of the Nanopatch Jet Coating Instrument, an advanced technology platform to support needle-free dermal drug delivery research and product development. The award was announced last evening at the Good Design Awards Gala Night held in Sydney, Australia.
A study by researchers at the UCLA Stroke Center found that stroke and cardiovascular disease have exacted an enormous toll on Hollywood stars.
› Verified 7 days ago
Ralph P Katz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1301 Barataria Blvd, Marrero, LA 70072 Phone: 504-347-0243 Fax: 504-349-2910 | |
Lucas Thomas Cashio, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 920 Avenue B, Marrero, LA 70072 Phone: 504-349-6804 Fax: 504-349-6844 | |
Matthew R Grimm, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Avenue B, Marrero, LA 70072 Phone: 504-349-6804 Fax: 504-349-6844 | |
Dr. Daniel James Gallagher, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4633 Wichers Dr, Marrero, LA 70072 Phone: 504-347-5421 Fax: 504-378-9331 | |
Mark Juneau Jr., M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 920 Avenue B, Marrero, LA 70072 Phone: 504-349-6804 Fax: 504-349-6844 | |
Chris J Digrado, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1301 Barataria Blvd, Marrero, LA 70072 Phone: 504-347-0243 Fax: 504-349-2910 |